Home
>
National Drug Code (NDC)
>
Zidovudine
Zidovudine - 53104-0100-4 - (zidovudine)
Drug Information of Zidovudine
| Product NDC: | 53104-0100 |
| Proprietary Name: | Zidovudine |
| Non Proprietary Name: | zidovudine |
| Active Ingredient(s): | 100 mg/1 & nbsp; zidovudine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zidovudine
| Product NDC: | 53104-0100 |
| Labeler Name: | Cipla Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078349 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070523 |
Package Information of Zidovudine
| Package NDC: | 53104-0100-4 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (53104-0100-4) |
NDC Information of Zidovudine
| NDC Code | 53104-0100-4 |
| Proprietary Name | Zidovudine |
| Package Description | 100 CAPSULE in 1 BOTTLE (53104-0100-4) |
| Product NDC | 53104-0100 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | zidovudine |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20070523 |
| Marketing Category Name | ANDA |
| Labeler Name | Cipla Limited |
| Substance Name | ZIDOVUDINE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
